| miR-375 targets 3′-phosphoinositide–dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic β-cells A El Ouaamari, N Baroukh, GA Martens, P Lebrun, D Pipeleers, ... Diabetes 57 (10), 2708-2717, 2008 | 527 | 2008 |
| MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic β-cell lines N Baroukh, MA Ravier, MK Loder, EV Hill, A Bounacer, R Scharfmann, ... Journal of Biological Chemistry 282 (27), 19575-19588, 2007 | 438 | 2007 |
| Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E–Deficient mice MA Ostos, M Conconi, L Vergnes, N Baroukh, J Ribalta, J Girona, ... Arteriosclerosis, thrombosis, and vascular biology 21 (6), 1023-1028, 2001 | 183 | 2001 |
| Apolipoprotein AV deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants I Grosskopf, N Baroukh, SJ Lee, Y Kamari, D Harats, EM Rubin, ... Arteriosclerosis, thrombosis, and vascular biology 25 (12), 2573-2579, 2005 | 177 | 2005 |
| Function of microRNA‐375 and microRNA‐124a in pancreas and brain NN Baroukh, E Van Obberghen The FEBS journal 276 (22), 6509-6521, 2009 | 136 | 2009 |
| Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice N Baroukh, E Bauge, J Akiyama, J Chang, V Afzal, JC Fruchart, EM Rubin, ... Arteriosclerosis, thrombosis, and vascular biology 24 (7), 1297-1302, 2004 | 109 | 2004 |
| IgG1 allotypes influence the pharmacokinetics of therapeutic monoclonal antibodies through FcRn binding D Ternant, C Arnoult, M Pugnière, C Dhommée, D Drocourt, E Perouzel, ... The Journal of Immunology 196 (2), 607-613, 2016 | 69 | 2016 |
| Myelination and motor coordination are increased in transferrin transgenic mice MC Saleh, A Espinosa de los Monteros, GA de Arriba Zerpa, I Fontaine, ... Journal of neuroscience research 72 (5), 587-594, 2003 | 61 | 2003 |
| Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodies C Passot, N Azzopardi, S Renault, N Baroukh, C Arnoult, M Ohresser, ... MAbs 5 (4), 614-619, 2013 | 60 | 2013 |
| Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis E Dalloneau, N Baroukh, K Mavridis, A Maillet, F Gueugnon, Y Courty, ... Oncotarget 7 (34), 54415, 2016 | 46 | 2016 |
| Optimization of sample preparation for metabolomics exploration of urine, feces, blood and saliva in humans using combined NMR and UHPLC-HRMS platforms C Martias, N Baroukh, S Mavel, H Blasco, A Lefèvre, L Roch, F Montigny, ... Molecules 26 (14), 4111, 2021 | 44 | 2021 |
| Expression of human apolipoprotein AI/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis L Vergnes, N Baroukh, MA Ostos, G Castro, N Duverger, MN Nanjee, ... Arteriosclerosis, thrombosis, and vascular biology 20 (10), 2267-2274, 2000 | 40 | 2000 |
| Expression and secretion of human apolipoprotein AI in the heart N Baroukh, CE Lopez, MC Saleh, D Recalde, L Vergnes, MA Ostos, ... FEBS letters 557 (1-3), 39-44, 2004 | 26 | 2004 |
| Fructose intake increases hyperlipidemia and modifies apolipoprotein expression in apolipoprotein AI-CIII-AIV transgenic mice MA Ostos, D Recalde, N Baroukh, MM Zakin, A Callejo, M Rouis, G Castro The Journal of nutrition 132 (5), 918-923, 2002 | 24 | 2002 |
| Expression of human apolipoprotein AI/C-III/A-IV gene cluster in mice reduces atherogenesis in response to a high fat-high cholesterol diet N Baroukh, MA Ostos, L Vergnes, D Recalde, B Staels, JC Fruchart, ... FEBS letters 502 (1-2), 16-20, 2001 | 24 | 2001 |
| Comparative genomic analysis reveals a distant liver enhancer upstream of the COUP-TFII gene N Baroukh, N Ahituv, J Chang, M Shoukry, V Afzal, EM Rubin, ... Mammalian genome 16, 91-95, 2005 | 23 | 2005 |
| A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen E Lereclus, M Tout, A Girault, N Baroukh, M Caulet, C Borg, O Bouché, ... BMC cancer 17, 1-8, 2017 | 19 | 2017 |
| Human apoA‐I/C‐III/A‐IV gene cluster transgenic rabbits: effects of a high‐cholesterol diet D Recalde, N Baroukh, C Viglietta, S Prince, J Verona, L Vergnes, ... FEBS letters 572 (1-3), 294-298, 2004 | 11 | 2004 |
| Human apolipoprotein A-IV reduces gastric acid secretion and diminishes ulcer formation in transgenic mice L Vergnes, N Baroukh, T Léhy, L Moizo, A Bado, M Baralle, FE Baralle, ... FEBS letters 460 (1), 178-181, 1999 | 9 | 1999 |
| Serum and Soleus Metabolomics Signature of Klf10 Knockout Mice to Identify Potential Biomarkers N Baroukh, N Canteleux, A Lefèvre, C Dupuy, C Martias, A Presset, ... Metabolites 12 (6), 556, 2022 | 7 | 2022 |
